English-language podcasts

Oral Arguments, with Context

Ingenus Pharmaceuticals, LLC v. Nexus Pharmaceuticals, Inc. — Fed. Cir. (Nov 5, 2026)

28 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

The Federal Circuit considers a patent dispute over a liquid formulation of cyclophosphamide, a drug used to treat cancer. The patent owner sued a competing manufacturer, alleging that its injectable product infringed the patent. A federal district court in Illinois ruled the patent invalid because its use of the word stable did not define the protected formulation with reasonable certainty. The patent owner is asking the Federal Circuit to reverse that ruling. The practical problem is knowing which test marks the boundary between the patented formulation and something competitors may make. One claim specifies limits on certain impurities after a week at elevated temperature and humidity. Another independent claim does not repeat those limits, and the patent also describes refrigeration. The patent owner will argue that the accelerated test supplies the controlling standard and that references to refrigeration do not create another claim requirement. The competitor will argue that this narrower interpretation was not presented below and does not resolve the uncertainty across the claims. Listen for whether the patent itself tells a skilled chemist what to measure and under which conditions, and whether the position now urged on appeal matches the one presented to the district court. The issue is the boundary of patent protection, not whether the medicine is safe or effective. Ingenus Pharmaceuticals, LLC v. Nexus Pharmaceuticals, Inc. (No. 25-1840) — U.S. Court of Appeals for the Federal Circuit, argued November 5, 2026. Sources: Argument audio — official Federal Circuit recording; complete argument, gentle volume compression only: Case and argument date — official Federal Circuit archive, docket 25-1840, November 5, 2026: Prior ruling and case background — Northern District of Illinois, Doc. 215, May 9, 2025; judgment of invalidity under review: Drug context only — FDA cyclophosphamide injection label, March 2025; not patent construction or medical advice:

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from Oral Arguments, with Context

Oral Arguments, with Context

Dickerson v. Macmillan, et al. — 9th Cir. (Nov 20, 2026)

41 min

The Ninth Circuit considers a shareholder's challenge to disclosures used to sell UserTesting. During negotiations, Thoma Bravo reduced a proposed ten-dollar-a-share offer to seven dollars and fifty cents. The board initially rejected that lower price, but later recommended a deal at that price to shareholders. The shareholder alleges that the merger's proxy statement wrongly made the company's revenue performance look worse than it was. The disputed sentence grouped revenue with calculated billings and said both had fallen short of expectations. Her theory is that this depressed picture helped persuade shareholders to accept too little for their stock. That is an allegation, not a finding that the deal was unfair. The district court dismissed the revised complaint. Although it had treated the disputed sentence as false or misleading, it said the allegations still sounded in fraud and failed the stricter requirements for pleading the executive's responsibility. The shareholder will arg

Discuss this episode

Oral Arguments, with Context

Canandaigua National Corporation v. Board of Governors of the Federal Reserve System — 2d Cir. (Nov 20, 2026)

42 min

The Second Circuit considers a plan to help homebuyers who need mortgages compete with cash offers. Canandaigua National Corporation, a New York financial holding company, wanted to guarantee purchases arranged through its mortgage subsidiary. If a preapproved customer failed to obtain final mortgage approval, the company would buy the home itself and later resell it. The proposal capped the value of homes held at any one time at five million dollars and promised resale within two years. Canandaigua says those safeguards make the risk small. The Federal Reserve Board rejected the plan on safety-and-soundness grounds, looking beyond the risk to this particular company. It did not finally decide the remaining statutory factors. Canandaigua will argue that the Board ignored the limits in its actual application. The Board will defend considering what could happen if financial holding companies generally began buying property under such guarantees. This is a dispute over permission for a pr

Discuss this episode

Oral Arguments, with Context

EcoHub, LLC v. Recology, Inc., et al. — 9th Cir. (Nov 20, 2026)

38 min

The Ninth Circuit hears a dispute over a proposed waste-processing project in California. Nortech already operated the Western Placer Waste Management Authority's facility. It worked with EcoHub on a proposal for the facility's future, first seeking a contract extension and then preparing for competitive bidding. The collaboration broke down. Nortech ended discussions after EcoHub failed to produce a requested financing commitment. EcoHub says the financing demand was a pretext, and that Recology pushed Nortech to abandon their joint effort. EcoHub and Nortech eventually submitted separate bids. Neither won. EcoHub nevertheless says their work together had already created a legal partnership, with duties Nortech could not simply walk away from. The district court ruled against EcoHub before trial, finding insufficient evidence of shared control. It also found EcoHub's interference claims against Recology were brought too late. EcoHub will argue that the companies' conduct and board dis

Discuss this episode

Community Poll

Supporters should be consulted before major changes in their club's ownership or location.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

A stray cat adopts you—and starts killing birds. Do you keep feeding it?

A stray cat visits your yard daily and appears to depend on the food you leave out. Neighbors complain that outdoor cats kill birds and say feeding it encourages the problem without taking responsibility for the animal.

Does caring for one visible animal excuse harm to less visible ones?

Explore this quandary